| Primary |
| Angiogram Retina |
57.1% |
| Angiogram |
16.3% |
| Diabetes Mellitus |
6.1% |
| Diabetic Retinopathy |
3.1% |
| Venous Occlusion |
3.1% |
| Deep Vein Thrombosis |
2.0% |
| Hypertension |
2.0% |
| Macular Degeneration |
2.0% |
| Retinal Vein Occlusion |
2.0% |
| Angiopathy |
1.0% |
| Chorioretinopathy |
1.0% |
| Csf Test |
1.0% |
| Diagnostic Procedure |
1.0% |
| Intraocular Pressure Test |
1.0% |
| Ophthalmological Examination |
1.0% |
|
| Loss Of Consciousness |
13.9% |
| Syncope |
12.9% |
| Nausea |
8.9% |
| Cerebrovascular Accident |
6.9% |
| Urticaria |
6.9% |
| Vomiting |
5.9% |
| Myocardial Infarction |
5.0% |
| Unresponsive To Stimuli |
5.0% |
| Urinary Incontinence |
5.0% |
| Heart Rate Decreased |
4.0% |
| Drug Hypersensitivity |
3.0% |
| Paraesthesia |
3.0% |
| Rectal Tenesmus |
3.0% |
| Tachycardia |
3.0% |
| Vertigo |
3.0% |
| Visual Acuity Reduced |
3.0% |
| Anaphylactic Reaction |
2.0% |
| Anaphylactoid Reaction |
2.0% |
| Bradycardia |
2.0% |
| Chills |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
25.0% |
| Diagnostic Procedure |
16.7% |
| Renal Impairment |
16.7% |
| Arteriosclerosis Obliterans |
8.3% |
| Drug Use For Unknown Indication |
8.3% |
| Glaucoma |
8.3% |
| Macular Degeneration |
8.3% |
| Ophthalmological Examination |
8.3% |
|
| Pyrexia |
33.3% |
| Dermatitis Contact |
16.7% |
| Eye Pain |
16.7% |
| Renal Impairment |
16.7% |
| Syncope |
16.7% |
|
| Concomitant |
| Hiv Infection |
16.0% |
| Angiogram |
12.0% |
| Antifungal Prophylaxis |
8.0% |
| Choroidal Neovascularisation |
8.0% |
| Diabetes Mellitus |
8.0% |
| Drug Use For Unknown Indication |
8.0% |
| Macular Degeneration |
8.0% |
| Prophylaxis |
8.0% |
| Retinopathy Of Prematurity |
8.0% |
| Chorioretinopathy |
4.0% |
| Neuropathy |
4.0% |
| Onychomycosis |
4.0% |
| Visceral Leishmaniasis |
4.0% |
|
| Hyperglycaemia |
18.2% |
| Macular Degeneration |
18.2% |
| Retinal Tear |
18.2% |
| Visual Acuity Reduced |
18.2% |
| Hypertension |
9.1% |
| Syncope Vasovagal |
9.1% |
| Tenosynovitis Stenosans |
9.1% |
|
